BORTHWICK KATHLEEN (SVP, Interim CFO) sold 7.2% of their position (3.18K shares) of PASSAGE BIO, INC. on the open market
Open‑market sale worth $1.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2025ACC: 0001415889-25-003728
Officer· SVP, Interim CFO
Since Jul 2023
-3.18K
Net shares
Net seller
$1.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8K acquired · 11.18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8K
Price / share
—
Trade value
—
% of position
21.9%
2/10/2025
36.47K→44.47K
Common Stock
Direct
Shares
−3.18K
Price / share
$0.53
Trade value
$1.69K
% of position
7.2%
2/11/2025
44.47K→41.28K
Total
Net shares
+4.82K
Net value
-$1.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2025 | M · Option Exercise | +8K | — | — | 21.9% | 36.47K | 44.47K |
| Common Stock Direct | 2/11/2025 | S · Sale | −3.18K | $0.53 | $1.69K | 7.2% | 44.47K | 41.28K |
| Total | +4.82K | -$1.69K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
8K shares
Shares
−8K
Strike price
Held after
0.00
Exercisable
—
2/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock8K shares | 2/10/2025 | M · Option Exercise | −8K | — | 0.00 |